Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: Results of multicenter survey in Japan

Stroke

Volumn 38, Issue 5, 2007, Pages 1430-1435

  Kuroda, Satoshi ^a   Hashimoto, Nobuo ^b   Yoshimoto, Takashi ^c,d   Iwasaki, Yoshinobu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Research Committee on Moyamoya Disease in Japan   (Japan)

Author keywords

Cerebral infarction; Disease progression; Intracranial bleeding; Moyamoya disease; Prognosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANASTOMOSIS; ANGIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HEMODYNAMICS; HOSPITAL; HUMAN; JAPAN; MALE; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; REVASCULARIZATION; SUPERFICIAL TEMPORAL ARTERY; TRANSIENT ISCHEMIC ATTACK;

ADOLESCENT; ADULT; AGED; CEREBRAL ANGIOGRAPHY; CEREBRAL INFARCTION; DISEASE PROGRESSION; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34247566568     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.106.478297     Document Type: Article

References (28)

1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-299.
2. Fukui M. Current state of study on moyamoya disease in japan. Surg Neurol. 1997;47:138-143.
3. Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S. Surgical therapy for adult moyamoya disease: can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke. 1996;27:1342-1346.
4. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg. 2000;93:976-980.
5. Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 1992;77:84-89.
6. Kuroda S, Houkin K, Ishikawa T, Nakayama N, Ikeda J, Ishii N, Kamiyama H, Iwasaki Y. Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis. Childs Nerv Syst. 2004;20:302-308.
7. Akasaki T, Kagiyama S, Omae T, Ohya Y, Ibayashi S, Abe I, Fujishima M. Asymptomatic moyamoya disease associated with coronary and renal artery stenoses: a case report. Jpn Circ J. 1998;62:136-138.
8. Nanba R, Kuroda S, Takeda M, Shichinohe H, Nakayama N, Ishikawa T, Houkin K, Iwasaki Y. [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease]. No Shinkei Geka. 2003;31:1291-1295.
9. Aoki T, Saiki M, Ishizaki R, Sato T. [A case report of the adult patient with asymptomatic moyamoya disease]. Pract Curren Neurosurg. 2004;14:597-602.
10. Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke. 2004;35:2837-2842.
11. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke. 2001;32:2110-2116.
12. Kaneko Y, Imamoto N, Mannoji H, Fukui M. Familial occurrence of moyamoya disease in the mother and four daughters including identical twins. Neurol Med Chir (Tokyo). 1998;38:349-354.
13. Yamauchi T, Houkin K, Tada M, Abe H. Familial occurrence of moyamoya disease. Clin Neurol Neurosurg. 1997;99 Suppl 2:S162-167.
14. Yamada M, Fujii K, Fukui M. [Clinical features and outcomes in patients with asymptomatic moyamoya disease-from the results of nation-wide questionnaire survey]. No Shinkei Geka. 2005;33:337-342.
15. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y. Epidemiological features of moyamoya disease in japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(Suppl 2):S1-S5.
16. Park-Matsumoto YC, Tazawa T, Shimizu J. Migraine with aura-like headache associated with moyamoya disease. Acta Neurol Scand. 1999;100:119-121.
17. Houkin K, Aoki T, Takahashi A, Abe H. Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke. 1994;25:2159-2164.
18. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam scan study. Stroke. 2003;34:1126-1129.
19. Shinkawa A, Ueda K, Kiyohara Y, Kato I, Sueishi K, Tsuneyoshi M, Fujishima M. Silent cerebral infarction in a community-based autopsy series in Japan: The Hisayama study. Stroke. 1995;26:380-385.
20. Ishikawa T, Kuroda S, Nakayama N, Terae S, Kudou K, Iwasaki Y. Prevalence of asymptomatic microbleeds in patients with moyamoya disease. Neurol Med Chir (Tokyo). 2005;45:495-500.
21. Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, Miki Y, Fushmi Y, Yamamoto A, Yamada K, Fukuyama H, Hashimoto N. Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg. 2005;102:470-475.
22. Grubb RL, Jr., Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, Spitznagel EL, Powers WJ. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA. 1998;280:1055-1060.
23. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002;33:1857-1862.
24. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, Konishi J, Shio H. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med. 1999;40:1992-1998.
25. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005;36:2148-2153.
26. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg. 1994;81:843-850.
27. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C. Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke. 1998;29:625-630.
28. JAM Trial Group. [Japan Adult Moyamoya (JAM) trial in 2002]. Surg Cereb Stroke. 2003;31:13-17.